STOCK TITAN

Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Bausch Health Companies Inc. (NYSE/TSX:BHC) has announced an update regarding its financing initiatives, revealing the engagement of J.P. Morgan to assist with its previously disclosed financing objectives. The company emphasizes that any potential transactions are subject to market conditions and other factors, with no guarantee of successful completion on acceptable terms.

Bausch Health Companies Inc. (NYSE/TSX:BHC) ha annunciato un aggiornamento riguardo le sue iniziative di finanziamento, rivelando l'impegno di J.P. Morgan per assistere nei suoi obiettivi di finanziamento precedentemente comunicati. L'azienda sottolinea che eventuali transazioni potenziali sono soggette a condizioni di mercato e altri fattori, senza alcuna garanzia di completamento con termini accettabili.

Bausch Health Companies Inc. (NYSE/TSX:BHC) ha anunciado una actualización sobre sus iniciativas de financiamiento, revelando el compromiso de J.P. Morgan para ayudar con sus objetivos de financiamiento previamente divulgados. La compañía enfatiza que cualquier transacción potencial está sujeta a condiciones de mercado y otros factores, sin garantía de éxito en la finalización bajo términos aceptables.

Bausch Health Companies Inc. (NYSE/TSX:BHC)는 자금 조달 이니셔티브에 대한 업데이트를 발표하며, J.P. Morgan이 이전에 공개된 자금 조달 목표를 지원하기 위해 참여하게 되었다고 밝혔습니다. 회사는 잠재적인 거래가 시장 조건 및 기타 요인에 따라 달라질 수 있으며, 수용 가능한 조건으로 성공적으로 완료될 것이라는 보장은 없다고 강조합니다.

Bausch Health Companies Inc. (NYSE/TSX:BHC) a annoncé une mise à jour concernant ses initiatives de financement, révélant l'engagement de J.P. Morgan pour aider à ses objectifs de financement précédemment divulgués. L'entreprise souligne que toute transaction potentielle est soumise aux conditions du marché et à d'autres facteurs, sans garantie de réussite de la finalisation dans des conditions acceptables.

Bausch Health Companies Inc. (NYSE/TSX:BHC) hat ein Update zu seinen Finanzierungsinitiativen angekündigt und die Einbindung von J.P. Morgan zur Unterstützung seiner zuvor bekannt gegebenen Finanzierungsziele offenbart. Das Unternehmen betont, dass potenzielle Transaktionen von den Marktbedingungen und anderen Faktoren abhängen und keine Garantie für einen erfolgreichen Abschluss zu akzeptablen Bedingungen besteht.

Positive
  • None.
Negative
  • None.

LAVAL, QC / ACCESS Newswire / March 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, today provided an update on its financing plans. The Company announced that it has engaged J.P. Morgan in connection with the Company's previously announced financing objectives.

Any transactions would be subject to market and other conditions and there can be no assurance that the Company will be able to successfully complete any transaction on acceptable terms or at all.

This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale, would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Bausch Health

Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements

This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:

Garen Sarafian
ir@bauschhealth.com
(877) 281-6642 (toll free)

Media Contact:

Katie Savastano
corporate.communications@bauschhealth.com
(908) 569-3692

SOURCE: Bausch Health Companies Inc.



View the original press release on ACCESS Newswire

FAQ

What is the purpose of Bausch Health's engagement with J.P. Morgan?

Bausch Health (BHC) has engaged J.P. Morgan to assist with its previously announced financing objectives.

Is there a guarantee that BHC's financing transactions will be completed?

No, the company states that transactions are subject to market conditions with no assurance of successful completion on acceptable terms.

When did Bausch Health announce its engagement with J.P. Morgan?

Bausch Health announced the engagement with J.P. Morgan on March 14, 2025.

What exchanges is Bausch Health (BHC) listed on?

BHC is dual-listed on the New York Stock Exchange (NYSE) and Toronto Stock Exchange (TSX).
Bausch Health Companies Inc

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Stock Data

2.56B
320.30M
11.26%
73.73%
2.24%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Canada
QUEBEC